|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01681 CONSUN PHARMA
Nominal 
14.130 +0.340 (+2.466%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Turnover | 1,784,688 | 13.777% | 1,568,588 | 1,268,549 | 1,119,679 | 993,528 |
| Cost of Sales | (332,620) | -7.582% | (359,907) | (321,026) | (283,263) | (255,437) |
| Gross Profit | 1,452,068 | 20.137% | 1,208,681 | 947,523 | 836,416 | 738,091 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (535) | -29.882% | (763) | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 698,339 | 30.473% | 535,238 | 433,958 | 377,605 | 309,517 | |
| Taxation | (100,195) | 209.349% | (32,389) | (32,998) | (29,775) | (13,877) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (2,835) | -37.692% | (4,550) | (1,195) | 64 | 1,089 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 595,309 | 19.468% | 498,299 | 399,765 | 347,894 | 296,729 | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Net Finance Costs / (Income) | (38,024) | -6.343% | (40,599) | (30,131) | (25,241) | (19,482) |
| Depreciation & Amortisation | 32,381 | 4.712% | 30,924 | 37,427 | 38,677 | 39,393 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| EPS (cts) | 71.000 | 20.339% | 59.000 | 50.000 | 44.080 | 37.430 |
| DPS (cts) | 32.879 | -- | 30.112 | 27.466 | 13.755 | 0.000 |
| Dividend Payout Ratio (%) | 46.308% | -- | 51.036% | 54.932% | 31.205% | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 5.674 | -- | 5.104 | 4.383 | 4.068 | 3.419 |
| Remarks: | Real time quote last updated: 28/08/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 595,309 |
| %Change | 19.468% |
| EPS / (LPS) | RMB 0.710 |
| NBV Per Share (¥) | RMB 5.674 |